Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to
your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Appointment
- Honorary Research Fellow
- Clinical and Movement Neurosciences
- UCL Queen Square Institute of Neurology
- Faculty of Brain Sciences
Biography
Eduardo is a Clinical Research Associate at the Reta Lila Weston Institute and Queen Square Brain Bank, at UCL Institute of Neurology. He also works as an Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery and leads the Parkinson's disease service at Darent Valley Hospital in Kent. His clinical interests include Parkinson's disease, parkinson-plus syndromes and other movement disorders.
Eduardo studied Medicine at Universidad Complutense in Madrid, qualifying in 2005. He trained as a clinical neurologist in Madrid and King's College Hospital in London where he completed a clinical fellowship in general neurology. He subsequently joined the Movement Disorders Centre at UCL Queen Square Institute of Neurology where he completed his PhD on the pathophysiology of non-motor symptoms in Parkinson's disease.
Research Summary
Eduardo's research focuses on the non-motor aspects of Parkinson's disease such as glucose metabolism, autonomic or gastrointestinal dysfunction, particularly in relation to their pathogenesis, influence on the clinical heterogeneity and disease progression. Using clinical and neuropathological studies combined with the exceptional resources of the Queen Square Brain Bank, Eduardo's research studies how some non-motor symptoms can increase the risk of developing Parkinson's disease or affect its progression. His research explores the potential pathogenic mechanisms involved in non-motor symptoms in order to provide more effective symptomatic treatments and ultimately identify therapeutic targets that can slow down the progression of Parkinson's disease.
